4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000033
Chief Scientific Officer sold 9,784 shares at an average $1.13 ($11,077)
From the SEC's structured data for this filing
Trades in this filing
Kishimoto Takashi Kei · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-04 | Sale : show line 1 in the form | −6,381 | $1.13 | $7,234 | 367,719 | D |
| 2023-01-04 | Sale : show line 2 in the form | −11 | $1.15 | $13 | 367,708 | D |
| 2023-01-05 | Sale : show line 3 in the form | −3,372 | $1.13 | $3,808 | 364,336 | D |
| 2023-01-05 | Sale : show line 4 in the form | −20 | $1.11 | $22 | 364,316 | D |
| Open-market sales · 9,784 sh · avg $1.13 · $11,077 | ||||||
Loading xslF345X03/wf-form4_167304333252079.xml…